A postmarket periodic safety report in the USA for approved biologic medicines, required by FDA regulations §§314.8(c)(2) and 600.808(c)(2).
Menu
A postmarket periodic safety report in the USA for approved biologic medicines, required by FDA regulations §§314.8(c)(2) and 600.808(c)(2).
Use our tool to look up the definition of terms in our glossary.
©2023 Trilogy Writing & Consulting GmbH | Impressum (Legal Information & Cookie Policy)